Gilbert Ortega, MD
Allergy & Immunology · Peoria, AZNPI 1003349242
Payments from drug & device makers
Across 622 payments — averaging $47.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$18K
- Sanofi$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Regeneron Healthcare Solutions, Inc.$2K
- GSK$970
- Grifols USA, LLC$499
- plus $5K from 34 others
What the payments were for
- Consulting fees$1,4855%
- Speaking & faculty fees$13,20044%
- Travel & lodging$7993%
- Food & beverage$14,10747%
- Education$1931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 134 | $18,013 |
| Sanofi | 36 | $2,428 |
| Takeda Pharmaceuticals U.S.A., Inc. | 72 | $1,592 |
| Regeneron Healthcare Solutions, Inc. | 67 | $1,569 |
| GSK | 48 | $970 |
| Grifols USA, LLC | 46 | $499 |
| Amgen | 23 | $468 |
| CSL Behring | 13 | $397 |
| Pfizer | 24 | $361 |
| Novartis | 17 | $357 |
| Optinose US, Inc. | 20 | $357 |
| Biocryst US Sales Co., LLC | 15 | $343 |
| Octapharma USA, Inc. | 1 | $331 |
| LEO Pharma Inc. | 17 | $274 |
| Genentech USA, Inc. | 9 | $203 |
| Galderma Laboratories, L.p. | 15 | $198 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $186 |
| Kaleo, Inc. | 5 | $145 |
| GC Biopharma USA, Inc. | 3 | $116 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Pharming Healthcare, Inc. | 4 | $94 |
| Blueprint Medicines Corporation | 3 | $79 |
| Baxter Healthcare | 5 | $75 |
| Incyte Corporation | 3 | $72 |
| Bio Products Laboratory USA, Inc. | 4 | $65 |
| Lilly USA, LLC | 2 | $63 |
| Ionis Pharmaceuticals, Inc. | 3 | $51 |
| Viatris Specialty LLC | 3 | $49 |
| AbbVie | 2 | $46 |
| ADMA Biomanufacturing LLC | 4 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Orthofix Medical, Inc. | 5 | $38 |
| Fresenius Kabi USA, LLC | 1 | $31 |
| DJO, LLC | 1 | $25 |
| Medtronic | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Covis Pharma GmbH | 1 | $16 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,784 in reported general payments places this provider in the 80th percentile of 90 allergy & immunology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 34 | $182,152 |
| Dupixent PenDupilumab | 15 | $93,289 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $57,094 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $28,741 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $6,701 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 39 | $5,700 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $5,328 |
| Epinephrine | 19 | $5,102 |
| Arnuity ElliptaFluticasone Furoate | 17 | $4,588 |
| Azelastine Hcl | 80 | $2,876 |
| Ipratropium Bromide | 46 | $1,379 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $1,187 |
| Fluticasone Propionate | 48 | $1,157 |
| Tacrolimus | 12 | $1,071 |
| Montelukast Sodium | 60 | $747 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $970 | $68,38371 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $18,013 | $34,06942 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 90 allergy & immunology providers in Arizona.
Other allergy & immunology in Peoria
- Gregory CowanPeoria$40K
- Ronald MittelPeoria$23K
- Mark RosePeoria$21K
- Ryan CasperPeoria$20K
- Ronald JorgensenPeoria$19K
- Kevin BoeselPeoria$15K
- Eiza ChingPeoria$12K
- Christine PrattPeoria$7K
- Levente ErdosPeoria$2K
- Connie HsuLitchfield Park$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.